Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Immunology and Infection / In Vitro ELISA Test for å evaluere Rabies vaksine …
JoVE Journal
Immunology and Infection

A subscription to JoVE is required to view this content.

JoVE Journal Immunology and Infection
In Vitro ELISA Test for å evaluere Rabies vaksine styrke
Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
Journal (Immunology and Infection)
Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
Retrograde Parotid Gland Infusion through Stensen's Duct in a Non-Human Primate for Vectored Gene Delivery
Journal (Immunology and Infection)
Retrograde Parotid Gland Infusion through Stensen's Duct in a Non-Human Primate for Vectored Gene Delivery
 
Click here for the English version

In Vitro ELISA Test for å evaluere Rabies vaksine styrke

Article DOI: 10.3791/59641-v • 09:04 min • May 11th, 2020
May 11th, 2020 •
1, 1,2
1Unit Antiviral Strategies, OIE Reference Laboratories for Rift Valley Fever Virus & Crimean Congo Hemorrhagic Fever Virus, Institut Pasteur, 2Institut Pasteur de Guinée, Conakry

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Her beskriver vi en indirekte ELISA sandwich immunocapture for å bestemme immungen glykoprotein innholdet i rabies vaksiner. Denne testen bruker et nøytraliserende monoklonalt antistoff (mAb-D1) som gjenkjenner glykoproteintrimmere. Det er et alternativ til in vivo NIH-testen for å følge konsistensen av vaksinepotens under produksjonen.

Tags

Immunologi og infeksjon Utgave 159 Rabies vaksinestyrke NIH-test ELISA-metode mAb-D1 monoklonalt antistoff Trimers av glykoprotein Glykoproteininnhold
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter